Summary of Classification and Labelling
Notified classification and labelling
General Information
280-427-9 |
5-(benzoylamino)-3-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, lithium sodium salt |
83400-12-8 |
Notified classification and labelling according to CLP criteria
Skin Sens. 1B |
H317
|
H317
|
|
GHS07 GHS09 Wng
|
M(Chronic)=1
|
|
|
|
2 |
|
View details
|
Aquatic Chronic 2 |
H411
|
H411
|
Skin Sens. 1B |
H317
|
H317
|
|
GHS07 Wng
|
|
|
|
|
13 |
|
View details
|
Not Classified |
|
|
|
|
|
|
|
|
7 |
|
|
Skin Sens. 1 |
H317
|
H317
|
|
GHS07 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 4